There are 383 resources available
101P - Clinicopathological features and behavior of ground glass opacity lung cancer associated with cystic airspace
Presenter: Ziwen Yu
Session: Poster Display session
102P - Comparison of clinical characteristics and prognosis of incidentally detected and screening detected lung cancers
Presenter: Sungmin Zo
Session: Poster Display session
103P - Effectiveness of artificial intelligence in retrospective COVID-19 lung CT analysis for lung cancer detection
Presenter: Sergei Pirgulov
Session: Poster Display session
104P - The potential for lung cancer detection in COVID-19 CT scans with AI technologies usage
Presenter: Swet Zinovev
Session: Poster Display session
105P - A model of workflow for radiomics signature of stage III non-small cell lung cancer (NSCLC) patients (pts)
Presenter: Alessandra Ferro
Session: Poster Display session
106P - Generation of synthetic ground glass opacities (GGOs) using generative adversarial networks (GANs)
Presenter: Zhixiang Wang
Session: Poster Display session
107P - Application of contrast clearance analysis (CCA) to assess viable tumour in non-small cell lung cancer (NSCLC) brain metastases post-stereotactic radiosurgery (SRS)
Presenter: Shybi MohamedKhan
Session: Poster Display session
110P - Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC
Presenter: Byoung Chul Cho
Session: Poster Display session
111P - Entrectinib in Chinese (mainland China, Hong Kong, Taiwan) patients (pts) with locally advanced/metastatic ROS1 fusion-positive (fp) NSCLC and NTRK-fp solid tumours
Presenter: Shun Lu
Session: Poster Display session
112P - Patient-reported outcomes (PROs) with first-line (1L) cemiplimab in patients with locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 1 subpopulation
Presenter: Igor Bondarenko
Session: Poster Display session